Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Suspended 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Warts 1Papilloma 1Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Maltose × Clear all
NCT01562626 2021-05-12

Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors

Anaeropharma Science, Inc.

Phase 1/2 Suspended
75 enrolled
Tumor-Agnostic

Neoplasms

NCT00454181 2011-09-16

Treatment of Oral Warts in HIV+ Patients

Ainos, Inc. (f/k/a Amarillo Biosciences Inc.

Phase 2 Completed
59 enrolled 13 charts

Acquired Immunodeficiency Syndrome, Papilloma, Warts, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡